Enter at least 4 characters

1 results showing for: 'lenalidomide (revlimid)'

-- Retail pharmacy- Specialist
- Special Authority SA2047

- Wastage claimable refer, page 1
  • Cap 5 mg
    • Brand Fully subsidised brand. Revlimid
    • Pharmacode2586339
    • Subsidy $5122.76
    • Measure / Qty per 28
    (Revlimid Cap 5 mg to be delisted 01 February 2025)
  • Cap 10 mg
    • Brand Fully subsidised brand. Revlimid
    • Pharmacode2293390
    • Subsidy $4655.25
    • Measure / Qty per 21
    • Brand Fully subsidised brand. Revlimid
    • Pharmacode2586312
    • Subsidy $6207.00
    • Measure / Qty per 28
    (Revlimid Cap 10 mg to be delisted 01 February 2025)
  • Cap 15 mg
    • Brand Fully subsidised brand. Revlimid
    • Pharmacode2369478
    • Subsidy $5429.39
    • Measure / Qty per 21
    • Brand Fully subsidised brand. Revlimid
    • Pharmacode2586320
    • Subsidy $7239.18
    • Measure / Qty per 28
    (Revlimid Cap 15 mg to be delisted 01 February 2025)
  • Cap 25 mg
    • Brand Fully subsidised brand. Revlimid
    • Pharmacode2331209
    • Subsidy $7627.00
    • Measure / Qty per 21
    (Revlimid Cap 25 mg to be delisted 01 February 2025)
SA2047 – Lenalidomide
  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply